| Imitrex Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Imitrex 50 mg | tablet | oral | 1.0 each | OTC |
| Imitrex 25 mg | tablet | oral | 1.0 each | OTC |
| Imitrex 100 mg | tablet | oral | 1.0 each | OTC |
| Imitrex 6 mg/0.5 mL | solution | subcutaneous | 0.5 milliliter(s) | OTC |
| Imitrex 6 mg/0.5 mL | kit | subcutaneous | 0.5 milliliter(s) | OTC |
Posted by shabbychic about 1 month ago
I am 39 and have had true migraine attacks since I was a child. I say true migraine attacks because they are different the...
Posted by mugsymom 4 months ago
I have had migraines since I was in my early 20's, I am now 56; however, I was never diagnosed and just endured them. About ...
Posted by rstynls9 4 months ago
I have had migraines since I was very young -- I'm 28 now. I currently take Topamax daily as preventative and the Imitrex is...
Staying at Par? - Motley Fool
Par plans to launch a generic version of GlaxoSmithKline's (NYSE: GSK) Imitrex in the fourth quarter and has a few more possibilities for 2009 and beyond, ...
Tue Mar 04 16:11:34 -0500 2008
Stronger Pharmaceutical Controls Urged - The Bahama Journal
... after a number of online pharmacies started catering to the Bahamian market, offering a growing list of drugs like Viagra, Levitra, Vioxx and Imitrex. ...
Wed Feb 27 02:04:55 -0500 2008
Stronger Pharmaceutical Controls Urged - The Bahama Journal
... after a number of online pharmacies started catering to the Bahamian market, offering a growing list of drugs like Viagra, Levitra, Vioxx and Imitrex. ...
Wed Feb 27 02:04:55 -0500 2008
sumatriptan succinate - The succinate salt form of sumatriptan, a member of the triptan class of compounds with anti-migraine property. Sumatriptan succinate selectively binds to and activates serotonin 5-HT1 receptors. This results in constriction of meningeal, dural, cerebral or pial blood vessels via stimulation of the 5-HT1B receptors, thereby reducing the vascular pulsation and may provide relief in migraine headaches. Furthermore, agonistic action of this agent through presynaptic stimulation of 5-HT1D and/or 5-HT1F receptors prevents release of vasoactive and pro-inflammatory neuropeptide (calcitonin gene-related peptide), thereby may also relieve migraine headaches. In addition, central inhibition of pain transmission via the inhibition of trigeminal neurons in the brain stems and upper spinal cord mediated by 5-HT1B, 5-HT1D or 5-HT 1F receptors also aides in the alleviation of migraine pain